Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Celsion Corp. | 1.560% | 0.000% | 5.785% | 0.787% | 115.126% | -90.725% | -95.224% |
India Globalization Capital | 10.480% | -9.871% | 3.960% | 62.791% | 60.305% | -65.058% | -54.521% |
Protara Therapeutics Inc. | -4.350% | -25.581% | -11.724% | -18.987% | 54.217% | -90.085% | - |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat